Logo

People in the News: Apr 28, 2011

Apr 28, 2011
Premium

Arrowhead Research said that it has appointed City of Hope researcher John Rossi to the scientific advisory board of subsidiary Calando Pharmaceuticals.

Rossi is one of Calando's co-founders. He also co-founded RNAi firm Dicerna Pharmaceuticals, and is a member of the SABs of Benitec and Kylin Therapeutics.

Filed under

Gene Editing, Gene Silencing, & CRISPR
RNAi
Calando
Arrowhead
Breaking News
The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.